Citi Downgrades Novartis Following SAG Investigation By: Benzinga via Benzinga March 29, 2016 at 10:10 AM EDT Citi has downgraded Novartis AG (ADR) (NYSE: NVS) to Neutral from Buy on SAG investigation. Analyst Andrew Baum reported, "The ongoing ... Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Eli Lilly Gsk Plc ADR Novartis Ag ADR Novo Nordisk A/S ADR Roche Holding AG Basel American Depositary Shares